Cerebral Embolic Protection Devices (CEPDs) During Transcatheter Aortic Valve Implantation (TAVI): A Meta‐Analysis of Randomized Controlled Trials

Documenti analoghi

• Evaluating Zero‐Contrast Transcatheter Aortic Valve Implantation (TAVI) for Patients With Renal Impairment: A Pooled Meta‐Analysis of 1505 Patients
  di: Ahmed Samy Badran, et al.
  Pubblicazione: (2025)
• Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Controlled Trials
  di: Kiarash Tavakoli, et al.
  Pubblicazione: (2025)
• Application of Single Versus Double‐ProGlide Devices for Vascular Access Closure After Transfemoral Transcatheter Aortic Valve Implantation in Korean Patients
  di: Yangyoun Lee, et al.
  Pubblicazione: (2025)
• Transcatheter Aortic Valve Replacement in Patients With Quadricuspid Aortic Valve: A Case Series and Systematic Review
  di: Wenjing Sheng, et al.
  Pubblicazione: (2025)
• Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1‐Year Comparative Study
  di: Mahmoud Balata, et al.
  Pubblicazione: (2025)